UPADACITINIB WAS NOT ASSOCIATED WITH ANAEMIA IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE U-ACHIEVE STUDY

被引：0
|
作者：
D'Haens, Geert R.
Hebuterne, Xavier
Higgins, Peter D.
Loftus, Edward V.
Zhou, Wen
Lacerda, Ana P.
Xie, Wangang
Liu, Jianzhong
Danese, Silvio
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1889
引用
收藏
页码：S1205 / S1206
页数：2
相关论文
共 50 条
  • [21] Correlation of histological assessment of mucosal healing with long-term clinical and patient-reported outcomes in patients with moderately to severely active ulcerative colitis treated with upadacitinib: results from the Phase 3 U-ACHIEVE maintenance trial
    Parkes, G.
    Ungaro, R.
    Danese, S.
    Abreu, M.
    Arenson, E.
    Zhou, W.
    Ilo, D.
    Laroux, F. S.
    Deng, H.
    Gonzalez, Y. Sanchez
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I476 - I477
  • [22] THE EFFECTS OF MAINTENANCE THERAPY WITH UPADACITINIB ON ABDOMINAL PAIN, BOWEL URGENCY, AND FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 U--ACHIEVE MAINTENANCE RESULTS
    Danese, Silvio
    Tran, Jacinda
    D'Haens, Geert R.
    Rubin, David T.
    Aoyama, Nobuo
    Zhou, Wen
    James, Barbara
    Yao, Xuan
    Gonzalez, Yuri Sanchez
    Panaccione, Remo
    GASTROENTEROLOGY, 2022, 162 (07) : S972 - S972
  • [23] Benefit-Risk Assessment of Upadacitinib Treatment in Patients With Moderately to Severely Active Ulcerative Colitis
    Panaccione, Remo
    Blumenstein, Irina
    Irving, Peter
    Vladea, Ramona
    Ilo, Dapo
    Zhou, Wen
    Levy, Gweneth
    Yao, Xuan
    Dotan, Iris
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S553 - S554
  • [24] A critical review of upadacitinib for the treatment of adults with moderately to severely active ulcerative colitis
    Law, Cindy C. Y.
    Kayal, Maia
    Mehandru, Saurabh
    Colombel, Jean-Frederic
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 17 (02) : 109 - 117
  • [25] Cost-Effectiveness Analysis of Upadacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in Greece
    Tzanetakos, Charalampos
    Psarra, Marina
    Kotsis, Ilias
    Gourzoulidis, George
    VALUE IN HEALTH REGIONAL ISSUES, 2025, 46
  • [26] COST-EFFECTIVENESS ANALYSIS OF UPADACITINIB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN GREECE
    Tzanetakos, C.
    Psarra, M.
    Kotsis, I
    Gourzoulidis, G.
    VALUE IN HEALTH, 2023, 26 (12) : S144 - S144
  • [27] Update on the role of upadacitinib in the treatment of adults with moderately to severely active ulcerative colitis
    Ernest-Suarez, Kenneth
    Panaccione, Remo
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [28] Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study
    Vermeire, Severine
    Danese, Silvio
    Zhou, Wen
    Ilo, Dapo
    Klaff, Justin
    Levy, Gweneth
    Yao, Xuan
    Chen, Su
    Gonzalez, Yuri Sanchez
    Hebuterne, Xavier
    Lindsay, James
    Higgins, Peter D. R.
    Cao, Qian
    Nakase, Hiroshi
    Colombel, Jean-Frederic
    Loftus, Edward V., Jr.
    Panaccione, Remo
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (11): : 976 - 989
  • [29] Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from, 52-week phase, 3 study U ACHIEVE maintenance
    Panes, J.
    Loftus, E. V. J.
    Higgins, P.
    Lindsay, J. O.
    Zhou, W.
    Yao, X.
    Ilo, D.
    Phillips, C.
    Tran, J.
    Sanchez Gonzalez, Y.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I373 - I374
  • [30] Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from, 52-week phase, 3 study U ACHIEVE maintenance
    Panes, J.
    Loftus, E. V. J.
    Higgins, P.
    Lindsay, O.
    Zhou, W.
    Yao, X.
    Ilo, D.
    Phillips, C.
    Tran, J.
    Gonzalez, Y. Sanchez
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I373 - I374
12345